Episode Details

Back to Episodes

Anticoagulants, Thrombolytics, and Antiplatelet Agents

Season 1 Episode 37 Published 3 years, 4 months ago
Description

Send us Fan Mail

This week, Rob and Zach will be talking about Anticoagulants, Thrombolytics, and Antiplatelet Agents

We will be discussing the following topics within this episode on Anticoagulants, Thrombolytics, and Antiplatelet Agents!

  • Hemostasis: Coagulation Cascade, Extrinsic + Intrinsic Pathway
  • Anticoagulants:
    • Heparin
      • UFH
      • LMWH
      • Fondaparinux 
    • Direct Factor Inhibitors
      • Xa Inhibitors:
        • Rivaroxaban
        • Apixaban
        • Edoxaban
      • Thrombin Inhibitors:
        • Dabigatran
        • Argatroban
        • Bivalirudin
    • Vitamin K Antagonists:
      • Warfarin (Coumadin)
  • Thrombolytics (tPA):
    • Alteplase
    • Reteplase
    • Tenecteplase
    • Streptokinase
    • Urokinase
  • Antiplatelets:
    • Aspirin
    • P2y12 Receptor Blockers:
      • Clopidogrel
      • Ticagrelor
      • Prasugrel
      • Ticlopidine
    • GP2b/3a Inhibitors:
      • Abciximab
      • Eptifibatide
      • Tirofiban
    • PDE-3 Inhibitors:
      • Cilostazol
  • Anticoagulants, Thrombolytics, Antiplatelet Agents MOA
  • Therapeutic Indications
  • Adverse Drug Reactions (ADR's)
  • Drug Complications

To follow along with Notes & Illustrations for our podcasts please become a member on our website! https://www.ninjanerd.org/podcast/anticoagulants-thrombolytics-and-antiplatelet-agents

Follow us on:

Support the show

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us